Results 11 to 20 of about 82,094 (282)
Cardiovascular Diabetology, 2022 Restenosis, defined as the re-narrowing of an arterial lumen after revascularization, represents an increasingly important issue in clinical practice.
Scott Wilson +10 more
doaj +4 more sources
THE CARDIOGRAM OF MITRAL RESTENOSIS [PDF]
Heart, 1963 Hala Mourad Demerdash, J. F. Goodwin
openalex +4 more sources
Cardiovascular Therapeutics, 2010 The introduction of coronary stents marked a major turning point in the practice of interventional cardiology. Whereas the efficacy of balloon angioplasty was challenged both by immediate mechanical complications and by a high incidence of restenosis, coronary stents offered cardiologists a means by which to not only augment immediate procedural ...
Michael S. Kim, Larry S. Dean
openaire +3 more sources
Restenosis begets restenosis: implications for stent selection [PDF]
Netherlands Heart Journal, 2008 Identifying the risk for restenosis is of critical importance in the stent selection process of patients undergoing percutaneous coronary intervention (PCI). Therefore, we sought to determine if a history of clinical recurrence (CR) after PCI increases the risk of CR after treatment of a de novo lesion in another coronary artery.We retrospectively ...
Jasper S. Wijpkema +5 more
openaire +4 more sources
FPR2 Agonism Attenuates Restenosis by Mitigating Neointimal Hyperplasia via ELOVL6. [PDF]
FASEB JRestenosis after revascularization in lower extremity arterial disease remains a major unmet need. We demonstrate reduced formylpeptide receptor 2 (FPR2) expression in human restenotic arteries and demonstrate that FPR2 deficiency exacerbates neointimal hyperplasia.
Zhang Q +8 more
europepmc +2 more sources
Endothelin and restenosis [PDF]
Cardiovascular Research, 1998 Time for primary review 31 days Percutaneous transluminal angioplasty (PTCA) was first introduced into the therapy of patients with coronary artery stenosis in the late seventies [1]. In the two decades since, this method has become standard therapy for patients suffering from all forms of coronary artery disease.
Klaus Münter, Michael Kirchengast
openaire +3 more sources
Implantation of paclitaxel-eluting stents in saphenous vein grafts: clinical and angiographic follow-up results from a multicentre study. [PDF]
, 2006 Objective: To define the clinical and angiographic follow-up results after implantation of paclitaxel-eluting stents (PESs) in stenotic saphenous vein grafts (SVGs). Design: Prospective multicentre study. Comparison with a control group.
Blindt, Ruediger +5 more
core +2 more sources
Predictors of In-Stent Restenosis [PDF]
Angiology, 2018 Abstract Not ...
Mehmet Kadri Akboga, Samet Yilmaz
openaire +4 more sources
Inhibition of in-stent stenosis by oral administration of bindarit in porcine coronary arteries [PDF]
, 2011 <p><b>Objective:</b> We have previously demonstrated that bindarit, a selective inhibitor of monocyte chemotactic proteins (MCPs), is effective in reducing neointimal formation in rodent models of vascular injury by reducing smooth ...
Baker, A.H. +10 more
core +1 more source